Although there were some confounding variables between the subjects, including the treatment status of HER2-targeted or hormonal therapy, cancer patients with hyperglycemic episodes had significantly higher NOTCH activity based on immunofluorescence staining of nuclear NOTCH1 (Fig. 6h, i). This evidence concerns the gene ERBB2 and cancer.